Athletes with medical conditions competing in FIVB and
continental competitions must obtain a TUE from the FIVB regardless of whether they have previously received a TUE at the national level.
The application for a TUE must be made as soon as possible (in case of an Athlete in the Registered Testing Pool, this would be when he/she is first notified of his/her inclusion in the pool) and no later than 30 days before the Athlete’s participation in the
event.
To obtain a TUE, fill out the
M-8 Form in print or type and send it to the FIVB enclosing all relevant medical files.
Please find here further information on TUE procedures.

The
List of Prohibited Substances and Methods (List), is the
International Standard that designates what is prohibited in- and
out-of competition. The List also indicates whether particular
substances are banned in particular sports. Substances and methods
are classified by categories (e.g. steroids, stimulants, gene
doping). The List is updated annually, published by October 1 and
comes into effect on January 1 of the following year. Click
here to
download the current version (valid as of January 1, 2017).

Whereabouts is information provided by a limited number of top
elite Athletes concerning their location to the International Sport
Federation (IF) or National Anti-Doping Organization (NADO) which
includes them in their respective Registered Testing Pool (RTP) as
part of these top elite Athletes’ Anti-Doping responsibilities.
Please find the following additional information here:

Athletes might get tested anytime and anywhere without previous
notice, no matter if they are included in an FIVB Registered Testing
Pool (RTP) or not. Generally we distinguish In-competition testing
and Out-of-competition testing. Click on WADA's Doping Control Video
to get an explanation of the entire procedure.

This video is also available in Arabic, French, German, Greek,
Portuguese, Russian and Spanish and can be accessed on
WADA's movies channel.

Be aware: Refusing, or failing without compelling justification, to
submit to Sample collection after notification as authorized in
applicable anti-doping rules or otherwise evading Sample collection
is considered as an anti-doping rule violation.

In addition, WADA's International Standard for Testing (IST) foresee procedures which assure and maintain the integrity of testing and identity of samples, from notifying the athlete to transporting samples for analysis, as well as regulations on Whereabouts requirements in order to conduct unannounced out-of-competition testing. Click
here to access IST.

Results Management is the process that deals with possible
Anti-Doping Rules Violations (ADRV), starting from the reporting of
an Adverse Analytical Finding (AAF), also called positive test –
when the laboratory reports the presence of a Prohibited Substance
or evidence of the use of a Prohibited Method in a sample after
analysis – until the final sanctioning of an athlete.
The above WADA doping control video also includes the Results Management process.
Once informed of an AAF, the Athlete has the following rights:

To request
for the B sample to be analyzed and to attend himself or via his
representative the identification, opening and analysis of the B
sample;

To request copies of the A and B Sample

laboratory documentation package;

Right of a
fair and timely hearing

The right to
appeal FIVB's decision which may be heard by the Court of Arbitration
for Sport (CAS)